Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study
CONCLUSIONS: Triplet therapy arrived in clinical practice primarily for synchronous high-volume mHSPC. Regardless of selected therapy regimen, treatment is highly effective and tolerable. Preferably therapy should be administered simultaneously, however if not possible, chemotherapy should be started first.PMID:38267304 | DOI:10.1016/j.clgc.2023.12.018 (Source: Clinical Prostate Cancer)
Source: Clinical Prostate Cancer - January 24, 2024 Category: Cancer & Oncology Authors: Mona Kafka Giulia Giannini Nastasiia Artamonova Hannes Neuwirt Heidemarie Ofner Gero Kramer Thomas Bauernhofer Ferdinand Luger Thomas H öfner Wolfgang Loidl Hubert Griessner Lukas Lusuardi Antonia Bergmaier Andreas Berger Thomas Winder Sarah Weiss Severi Source Type: research
Cancer screening in people with HIV: Implementation in clinical practice and barriers perceived by medical specialists in Spain
CONCLUSIONS: There are barriers and opportunities to expand cancer screening programmes in PLHIV, especially in colorectal, anal and lung cancers. It is necessary to allocate resources for the early detection of cancer in PLHIV, but also to disseminate CPGs screening recommendations among medical specialists.PMID:38262880 | DOI:10.1016/j.eimce.2024.01.007 (Source: Clinical Prostate Cancer)
Source: Clinical Prostate Cancer - January 23, 2024 Category: Cancer & Oncology Authors: F élix Gutiérrez Sergio Padilla Javier Garc ía-Abellán Ana Guti érrez-Ortiz de la Tabla Christian Ledesma Mar Masi á Source Type: research
Impact of prostate position-based image-guidance in intensity-modulated radiation therapy for localized prostate cancer
CONCLUSIONS: The use of P-IGRT with higher doses and smaller margins was correlated with significantly better biochemical control, and a lower incidence of rectal bleeding in IMRT for intermediate-risk prostate cancer. The enhanced accuracy using P-IGRT has the potential to independently improve disease control and reduce late rectal bleeding.PMID:38191958 | DOI:10.1007/s10147-023-02456-1 (Source: Clinical Prostate Cancer)
Source: Clinical Prostate Cancer - January 9, 2024 Category: Cancer & Oncology Authors: Rihito Aizawa Haruo Inokuchi Itaru Ikeda Kiyonao Nakamura Takashi Ogata Shusuke Akamatsu Takayuki Goto Kimihiko Masui Takayuki Sumiyoshi Yuki Kita Takashi Kobayashi Takashi Mizowaki Source Type: research
RE : « Conversation entre un biologiste clinicien et une intelligence artificielle sur les biomarqueurs du cancer de la prostate »
Ann Biol Clin (Paris). 2024 Jan 1;81(6). doi: 10.1684/abc.2023.1849. Online ahead of print.NO ABSTRACTPMID:38189337 | DOI:10.1684/abc.2023.1849 (Source: Clinical Prostate Cancer)
Source: Clinical Prostate Cancer - January 8, 2024 Category: Cancer & Oncology Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research
Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI
CONCLUSION: Prostate MRI benefits from reader experience. Less experienced readers missed a relevant proportion of csPC with mpMRI and even more with bpMRI. The overall performance of expert readers was comparable for mpMRI and bpMRI but DCE enabled detection of some further ISUP 2 PC.PMID:38185579 | DOI:10.1016/j.crad.2023.11.026 (Source: Clinical Prostate Cancer)
Source: Clinical Prostate Cancer - January 7, 2024 Category: Cancer & Oncology Authors: F Ziayee L Schimm öller M Boschheidgen L Kasprowski R Al-Monajjed M Quentin J P Radtke P Albers G Antoch T Ullrich Source Type: research
